Search results for "From ACP Internist"
Managing patients with diabetes and heart failure
Conference coverage from the Heart Failure Society of America's annual meeting focuses on patients with both diabetes and heart failure.
https://diabetes.acponline.org/archives/2019/11/08/8.htm
8 Nov 2019
Watch out for NAFLD, and help patients get more exercise
The April ACP Internist looked at two issues related to diabetes— the high prevalence of nonalcoholic fatty liver disease (NAFLD) and how some internists have succeeded in getting their patients to exercise more.
https://diabetes.acponline.org/archives/2021/04/09/6.htm
9 Apr 2021
Preventing and treating diabetic nephropathy
Managing kidney disease in diabetes requires meeting individualized parameters and balancing risks in nephrology and cardiology, according to experts featured in a recent article in ACP Internist.
https://diabetes.acponline.org/archives/2012/11/09/6.htm
9 Nov 2012
Paternal metformin use associated with major birth defects
A prospective registry-based study in Denmark found that offspring of men who filled one or more prescriptions for metformin during the three months of developing fertilizing sperm were more likely to have a birth defect, while insulin and sulfonylureas were not associated with increased risk.
https://diabetes.acponline.org/archives/2022/04/08/6.htm
8 Apr 2022
Teaching diabetes self-management ‘basic survival skills'
Diabetes self-management education is a cost-efficient, effective treatment that is underused in the United States, according to speakers at the 2012 annual meeting of the American Diabetes Association.
https://diabetes.acponline.org/archives/2012/09/14/8.htm
14 Sep 2012
Diabetes debates defy easy resolution
Learn what speakers at the American Diabetes Association's 73rd Scientific Sessions said about use of sulfonylureas, diabetes and osteoporosis, and concentrated insulin in the September ACP Internist.
https://diabetes.acponline.org/archives/2013/09/13/7.htm
13 Sep 2013
Diabetic foot care begins with bare feet
Get advice on heading up a care team that intervenes early and often to prevent the ulcerations, pressure points and neuropathies that can progress to infection and possibly amputation in the October ACP Internist.
https://diabetes.acponline.org/archives/2013/10/11/7.htm
11 Oct 2013
New recommendations advise on adding SGLT-2 inhibitors and GLP-1 receptor agonists
A new guideline from The BMJ strongly recommends sodium-glucose cotransporter-2 (SGLT-2) inhibitors for patients with diabetes and established cardiovascular and chronic kidney disease, in addition to offering weaker support for starting glucagon-like peptide-1 (GLP-1) receptor agonists in this same patient population.
https://diabetes.acponline.org/archives/2021/06/11/7.htm
11 Jun 2021
ADA updates diabetes standards of care for 2023
The American Diabetes Association (ADA) has changed its recommendations on hypertension cutoffs, use of statins, and treatment of patients with diabetes and chronic kidney disease, among other topics.
https://diabetes.acponline.org/archives/2023/01/13/5.htm
13 Jan 2023
SGLT-2 inhibitors not associated with increased risk for severe UTIs
An accompanying editorial said that while the study's finding is reassuring, it should be considered with caution, especially since high-risk patients and those with previous urinary tract infections (UTIs) were excluded.
https://diabetes.acponline.org/archives/2019/08/09/7.htm
9 Aug 2019